Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Completed 38Withdrawn 9Active not recruiting 8Recruiting 6Unknown 5Terminated 5Not yet recruiting 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 3Head & Neck 1Breast 1

Conditions

Prostatic Neoplasms 2Triple Negative Breast Neoplasms 1Salivary Gland Neoplasms 1Paget Disease, Extramammary 1Non-Muscle Invasive Bladder Neoplasms 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × bicalutamide × Clear all
NCT07455903 2026-05-13

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Baptist Health South Florida

Phase 2 Recruiting
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT06145308 2026-04-02

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Peking Union Medical College

Phase 2 Recruiting
39 enrolled
Head & Neck

Salivary Gland Neoplasms

NCT06365788 2026-04-01

ABBICAR

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting
53 enrolled
Breast

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT04734730 2026-01-28

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

City of Hope Medical Center

Phase 2 Recruiting
70 enrolled
Genitourinary

Prostatic Neoplasms

NCT05327647 2025-12-18

BicaBCa

CHU de Quebec-Universite Laval

Phase 2 Recruiting
160 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07117851 2025-08-12

A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

Fudan University

Phase 2 Recruiting
20 enrolled

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡